UBS Downgrades CME Group (CME) to Neutral

July 24, 2025 1:00 AM EDT Send to a Friend
UBS analyst Alex Kramm downgraded CME Group (NASDAQ: CME) from Buy to Neutral with a price target of $305.00.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login